Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging

Stem Cells

Volumn 27, Issue 7, 2009, Pages 1548-1558

  Wang, Hui ^a   Cao, Feng ^a   De, Abhijit ^a   Cao, Yuan ^a   Contag, Christopher ^a   Gambhir, Sanjiv S ^a   Wu, Joseph C ^a   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipogenesis; Bioluminescence imaging; Mesenchymal stem cell; Molecular imaging; Multipotent differentiation; Osteoblastogenesis

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; BIOLUMINESCENCE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENGRAFTMENT; ENZYME ISOLATION; FEMALE; FLOW CYTOMETRY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PLANT GROWTH; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC;

MURINAE; MUS; MUS MUSCULUS; RENILLA LUCIFERASE;

EID: 68049147001     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.81     Document Type: Article

References (54)

1. Ren C, Kumar S, Chanda D et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther 2008;15:1446-1453.
2. Ren C, Kumar S, Chanda D et al. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 2008;26:2332-2338.
3. Mohr A, Lyons M, Deedigan L et al. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model. J Cell Mol Med 2008;12:2628-2643.
4. Kucerova L, Matuskova M, Pastorakova A et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 2008;10:1071-1082.
5. Hall B, Dembinski J, Sasser AK et al. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 2007;86:8-16. (Pubitemid 47204483)
6. Fritz V, Jorgensen C. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Curr Stem Cell Res Ther 2008;3:32-42. (Pubitemid 352024865)
7. Duan X, Guan H, Cao Y et al. Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. Cancer 2009;115:13-22.
8. Bexell D, Gunnarsson S, Tormin A et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2009;17:183-190.
9. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008;15:739-752. (Pubitemid 351627357)
10. Xie X, Cao F, Sheikh AY et al. Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells 2007;9:549-563.
11. Krishnan M, Park JM, Cao F et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J 2006;20:106-108. (Pubitemid 43100482)
12. Klopp AH, Spaeth EL, Dembinski JL et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 2007;67:11687-11695.
13. Miyagawa T, Gogiberidze G, Serganova I et al. Imaging of HSV-tk reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med 2008;49:637-648.
14. Doubrovin MM, Doubrovina ES, Zanzonico P et al. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res 2007;67:11959-11969.
15. Wu JC, Tseng JR, Gambhir SS. Molecular imaging of cardiovascular gene products. J Nucl Cardiol 2004;11:491-505. (Pubitemid 39107086)
16. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-580.
17. Caplan AI. The mesengenic process. Clin Plast Surg 1994;21:429-435.
18. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 2001;187:265-276.
19. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584. (Pubitemid 37280136)
20. Gordeladze JO, Noel D, Bony C et al. Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis. Exp Cell Res 2008;314:1495-1506.
21. Lee KS, Kim HJ, Li QL et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000;20:8783-8792.
22. Alliston T, Choy L, Ducy P et al. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001;20:2254-2272. (Pubitemid 32410595)
23. Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-37734. (Pubitemid 37384014)
24. Karsenty G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology 2001;142:2731-2733. (Pubitemid 32575505)
25. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603-3608. (Pubitemid 34728832)
26. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-1603. (Pubitemid 39534883)
27. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-313.
28. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441. (Pubitemid 38586721)
29. Jones OY, Good RA, Cahill RA. Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis. Bone Marrow Transplant 2004;33:1061-1063. (Pubitemid 38744795)
30. El-Badri NS, Maheshwari A, Sanberg PR. Mesenchymal stem cells in autoimmune disease. Stem Cells Dev 2004;13:463-472. (Pubitemid 39473577)
31. Lazarus HM, Koc ON, Devine SM et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-398.
32. Cao YA, Wagers AJ, Beilhack A et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 2004;101:221-226. (Pubitemid 38084231)
33. Sheikh AY, Lin SA, Cao F et al. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells 2007;25:2677-2684. (Pubitemid 47582761)
34. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci U S A 2002;99:377-382. (Pubitemid 34060369)
35. Park SR, Oreffo RO, Triffitt JT. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 1999;24:549-554.
36. Oreffo RO, Virdi AS, Triffitt JT. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 1997;74:251-261. (Pubitemid 27490216)
37. Xu C, Jiang J, Sottile V et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 2004;22:972-980. (Pubitemid 39507084)
38. Schrepfer S, Deuse T, Reichenspurner H et al. Stem cell transplantation: the lung barrier. Transplant Proc 2007;39:573-576. (Pubitemid 46386222)
39. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
40. Kanehira M, Xin H, Hoshino K et al. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Ther 2007;14:894-903. (Pubitemid 47557220)
41. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-3318. (Pubitemid 40524615)
42. Spaeth E, Klopp A, Dembinski J et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008;15:730-738. (Pubitemid 351627356)
43. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-3844. (Pubitemid 37409409)
44. Yu JM, Jun ES, Bae YC et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008;17:463-473.
45. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549. (Pubitemid 38420184)
46. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685. (Pubitemid 38387752)
47. Al-Khaldi A, Al-Sabti H, Galipeau J et al. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 2003;75:204-209. (Pubitemid 36099048)
48. Khakoo AY, Pati S, Anderson SA et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006;203:1235-1247. (Pubitemid 43736593)
49. Eliopoulos N, Stagg J, Lejeune L et al. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005;106:4057-4065. (Pubitemid 41775910)
50. Allers C, Sierralta WD, Neubauer S et al. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004;78:503-508. (Pubitemid 39097094)
51. Wolf D, Rumpold H, Koeck R et al. Re: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents [letter]. J Natl Cancer Inst 2005;97:540-541; author reply 541-542. (Pubitemid 40590437)
52. Tocci A, Forte L. Mesenchymal stem cell: use and perspectives. Hematol J 2003;4:92-96. (Pubitemid 36748510)
53. Valable S, Barbier EL, Bernaudin M et al. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 2008;40:973-983.
54. Dwyer RM, Potter-Beirne SM, Harrington KA et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007;13:5020-5027.